Paradigm Biopharmaceuticals | PAR - Market Capitalization

Stock Price
0.30
Daily Change
-0.02 -4.76%
Monthly
-18.92%
Yearly
-44.95%
Q1 Forecast
0.30

Paradigm Biopharmaceuticals reported AUD105.36M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Avita Medical AUD 140.79M 194.8M Jun/2025
Medical Developments International AUD 61.96M 16.34M Jun/2025
Neuren Pharmaceuticals AUD 1.75B 152.5M Jun/2025
Pacific Edge NZD 194.21M 87.84M Dec/2025
PYC Therapeutics AUD 755.32M 139.4M Jun/2025
Telix Pharmaceuticals AUD 10.88B 2.64B Jun/2025